Related Experiment Video
Updated: May 26, 2026

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
Covalent tumor anchoring spatially orchestrates antitumor immunity
Qingke Li1, Hongfei Chen1, Pan Zhang1
1Department of Pharmaceutical Chemistry, the Cardiovascular Research Institute, and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158, USA.
Covalently anchored tumor immunotherapeutic proteins (CATIPs) immobilize immune cues on tumor cells, enhancing tumor rejection. This approach limits systemic toxicity and generates durable antitumor immunity.
Area of Science:
- Oncology
- Immunology
- Biotechnology
- Protein Engineering
Background:
- Protein immunotherapies show promise for tumor rejection but suffer from limited spatial control due to reversible target engagement and systemic leakage.
- Current methods often lead to off-target effects and systemic immunopathology, necessitating improved strategies for localized and sustained therapeutic action.
Purpose of the Study:
- To develop a novel platform of covalently anchored tumor immunotherapeutic proteins (CATIPs) for enhanced spatial control and efficacy.
- To evaluate the therapeutic potential of CATIPs in preclinical models, assessing their ability to induce durable, tumor-specific antitumor immunity while minimizing systemic toxicity.
Main Methods:
- Development of a modular CATIP platform utilizing proximity-enabled covalent chemistry to immobilize immune cues on tumor cell surfaces.
- CATIPs were engineered with tumor-targeting nanobodies and payloads for T cell engagement, co-stimulation, and cytokine support.
- Preclinical evaluation in human PBMC-reconstituted NSG mice with EGFR-positive tumors and immunocompetent melanoma models.
Main Results:
- CATIPs completely eradicated EGFR-positive tumors in NSG mice, outperforming non-covalent protein therapies.
- Treatment with CATIPs significantly limited systemic T cell activation, cytokine release, and xGVHD-associated morbidity.
- In melanoma models, CATIPs remodeled the tumor microenvironment, expanded CD8+ T cells, induced abscopal control, and generated durable protection against tumor rechallenge.
Conclusions:
- Covalent tumor anchoring of immunotherapeutic proteins converts local delivery into effective tumor-surface immune programming.
- CATIPs enable potent, tumor-specific, and durable antitumor immunity with reduced systemic immunopathology and off-target toxicity.
- CATIP-engineered tumor cells can serve as effective whole-cell vaccines, highlighting the platform's versatility.
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

